chrisvoncsefalvay/vaers-outcomes huggingface dataset:
On and off pain in his chest- myocarditis; Chest pain radiates from his front to back; Patient is a little a little scared; This spontaneous case was reported by a consumer and describes the occurrence of MYOCARDITIS (On and off pain in his chest- myocarditis) in a 38-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 033C21A and 039C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 24-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MYOCARDITIS (On and off pain in his chest- myocarditis) (seriousness criterion medically significant), CHEST PAIN (Chest pain radiates from his front to back) and FEELING ABNORMAL (Patient is a little a little scared). The patient was treated with IBUPROFEN at an unspecified dose and frequency and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, MYOCARDITIS (On and off pain in his chest- myocarditis), CHEST PAIN (Chest pain radiates from his front to back) and FEELING ABNORMAL (Patient is a little a little scared) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Jun-2021, Body temperature increased: 37.5c' (Inconclusive) Temperature increased to 37.5C'.     mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       The patient stated that he received his first dose of the Moderna COVID-19 vaccine on 24 May 2021 and his second dose on 21 Jun 2021 at a local Pharmacy. He was fine following the first dose. The second day after receiving the second dose, he had a temperature that increased to 37.5 C. He took Ibuprofen and Tylenol as treatment medications, which helped. About 5 days ago, he started having on and off pain in his chest- myocarditis, and the pain radiated from his front to back. He was a little scared, as he had read on the CDC website that myocarditis is a side effect of the Moderna COVID-19 vaccine. He has never experienced symptoms like these before, as he is athletic but has not worked hard. Hence, the side effect was strange to him. He planned to call his doctor on Monday 5 Jul 2021.  No concomitant medication was provided by the reporter.  Very limited information regarding these events has been provided at this time.  Further information has been requested.; Sender's Comments: Very limited information regarding these events has been provided at this time.  Further information has been requested.
10/24/2022  I woke up at 3:00AM to go to the bathroom and there was blood in my urine. It occurred three times.  The next morning I went to see my physician.  He had me go see my Urologist. My appointment was on 11/3/22.  I had a cystoscopy on 12/29/22 and was diagnosed with cancer. I had a biopsy done on 1/4/23 and found it was cancer and invasive. I was referred to an oncologist. I saw my Oncologist.1/19/2023 I had a PET Scan of my bladder, my cancer had not metastasized. He referred me to a Radiologist Oncologist and a Urology Oncologist. On 2/6/23 I saw the Urology Oncologist and on 3/1/23 he did another biopsy with blue , unknown name.  He also did a PURBT. It was determined it was a high grade non muscle invasive bladder cancer. All cancer was removed and no evidence of metastasis.  We are now looking at Adjuvant Therapy, a follow up therapy.  This is a trial, so it will be one of two drugs. Once a week for six weeks they will inject this into my bladder. The follow up will be three to five  years , depending on which drug it is,and they will be doing blood tests, cystoscopy, CT scans and PET scans. My next appointment is on 3/28/23 to do bloodwork and get set up for the trial.
This spontaneous report was received from a licensed practical nurse and referred to an unspecified number of patient of unknown age and sex. No pertinent medical history, drug reactions or allergies were reported. On an unknown date the unspecified number of patients have been administered MMR II (lot #, expiration date, dose and route of administration were not reported) injection for prophylaxis as a vaccination which was exposed to temperatures outside the prescribing information although were supported. No adverse effects were reported. No concomitant medications were reported. Follow up information has been received. The reported provided the MMR II therapy type was HSA, lot # was H017027 and expiration date was 14-SEP-2014. The nurse reported also that no doses were administered. This case is linked to case number 1403USA007007 and 1403USA005427. Additional information is not expected.
7 days after vaccine she developed erythema and warmth and tenderness surrounding the injection site.
Red, itchy, small bumps on torso and back starting 2 days after vaccine - getting itchier. Sore throat.
pt recv vax AUG96 & OCT96 pt exp genital herpes;no further details were provided;
Patient received a dose of Moderna vaccine today as his second dose, in error.  His first vaccine was Pfizer (Lot EW0179), received on 5/4/21.  Patient was informed of the error and was observed for 45 minutes.
patient presented to the pharmacy with a palm-sized red, raised area on the upper left arm near where the vaccine was given
Started feeling poor at work after receiving flu shot. Felt dizzy, headache, body aches, and warm. When I arrived home, I checked my temperature and it was 102.6.
Patient called to ask if they should still being having arm pain. She says she does a lot of physical labor at work and has been having difficulties with her left arm. She said she is unable to lift it at all and still has a bit of pain. She wanted to know how long this pain could last and when she had her flu shot.
pt recvd vax & had high pitched cry; would not nurse; t 99.9; pt vomited then started w/ a congestion & runny nose;
couldn't walk; couldn't do anything for 2 or 3 days; crippled; "The Moderna vaccine totally put her on a position of not being able to move"; This spontaneous case was reported by a consumer and describes the occurrence of GAIT DISTURBANCE (couldn't walk), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (couldn't do anything for 2 or 3 days), VACCINATION COMPLICATION (crippled) and MOBILITY DECREASED ("The Moderna vaccine totally put her on a position of not being able to move") in a 39-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced GAIT DISTURBANCE (couldn't walk), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (couldn't do anything for 2 or 3 days), VACCINATION COMPLICATION (crippled) and MOBILITY DECREASED ("The Moderna vaccine totally put her on a position of not being able to move"). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency and ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) at an unspecified dose and frequency. At the time of the report, GAIT DISTURBANCE (couldn't walk), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (couldn't do anything for 2 or 3 days), VACCINATION COMPLICATION (crippled) and MOBILITY DECREASED ("The Moderna vaccine totally put her on a position of not being able to move") outcome was unknown.            The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was not applicable  No concomitant medications reported.
Severe menstrual cramping and out-of-cycle bleeding starting 2-3 days following dose. On-going at time of reporting the adverse event.
Rhabdomylitis, hyponatremia, hypovolemia, Elevated Creatinine Kinase.  Patient went to ER for body aches 6/28/21 and was sent back to ER by PCP after telephone visit on 6/29/21.  Patient was admitted to Hospital
Information has been received from a healthcare worker concerning a male patient who on 11-DEC-2008 was vaccinated intramuscularly with a 0.5 ml dose of PNEUMOVAX (lot #659921/1679U). The healthcare worker reported that the patient had a fever of 104F and huge inflammation at the injection site. The patient called the medical line on 13-DEC-2008 or 14-DEC-2009 and was treated with BIAXIN. A lot search was requested. The patient sought unspecified medical attention. It was also reported that the patient was vaccinated with a dose of PNEUMOVAX at least 5 years ago. A standard lot check investigation was performed. All in-process quality checks for the lot number in question were satisfactory. The lot met the requirements of the Center and was released. Additional information has been requested.
Pain in right arm pit (same arm of injection); Little lump in right arm pit (same arm of injection); This spontaneous case was reported by a consumer and describes the occurrence of AXILLARY PAIN (Pain in right arm pit (same arm of injection)) and AXILLARY MASS (Little lump in right arm pit (same arm of injection)) in a 26-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Apr-2021, the patient experienced AXILLARY PAIN (Pain in right arm pit (same arm of injection)) and AXILLARY MASS (Little lump in right arm pit (same arm of injection)). At the time of the report, AXILLARY PAIN (Pain in right arm pit (same arm of injection)) and AXILLARY MASS (Little lump in right arm pit (same arm of injection)) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment information was reported. Concomitant product use was not provided by the reporter.
Patient was light headed and nauseous after 911 call paramedics arrived no treatment was administered/she got better after a drink of orange juice and some rest.
Sudden, spreading, extremely painful joint inflammation starting at the right shoulder, days later the right knee and left middle toe ball joint, followed by the same in left knee. Otherwise healthy person with no preexisting conditions.
Immediate light headedness 1 minute post administration progressing to chest pain and tightness along with abdominal pain/cramping approximately 2 minutes later. EMT's contacted. Checked patient's blood pressure which had dropped to 96/50 mmHg. Provided water to patient 2 minutes later to re stabilize cardiovascular stability. Chest pain and lightheadedness ceased within 1 minute after providing 16 ounces of water. Checked blood pressure again which   returned to 110/69 mmHg. EMT's arrived approximately 20 minutes after administration and patient was assessed. Blood pressure noted at 126/70 mmHg. Patient was allowed to go home with slight, residual abdominal pain.
Rash at injection site, spread, w/ splotchy raised red areas at other locations. Seemed itchy.
flu-like symptoms; This case was reported by a other health professional via sales rep and described the occurrence of influenza-like symptoms in a patient who received Men B NVS (Bexsero) for prophylaxis.   On an unknown date, the patient received Bexsero at an unknown dose. On an unknown date, unknown after receiving Bexsero, the patient experienced influenza-like symptoms. On an unknown date, the outcome of the influenza-like symptoms was unknown.   It was unknown if the reporter considered the influenza-like symptoms to be related to Bexsero.  Additional details were provided as follows: The age at vaccination was not reported. The medical assistant mentioned she had one call back with Bexsero since office implanted a few months ago. The medical assistant stated that the patient called complaining about flu-like symptoms. The reporter did not give permission for follow up contact.
Patient presented to the ED and was subsequently hospitalized within 6 weeks of receiving COVID vaccination. Diagnosis was anemia.
Severe headache, aching arm, numb lips, pain in neck, swollen arm, chest pains, sweating.
1 of 5 pts w/in a 3 wk period who exp cellulitis following vax; treated w/ATB (augmentin for 7-10 days; no culture taken;
Continued fatigue and headaches progressing from two weeks after vaccine to today. No treatment options pursued. Received a CBC panel.
she found out that she was pregnant through a home pregnancy test; 1st dose given on 28Apr2021 (more than 36 days ago); This spontaneous case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (she found out that she was pregnant through a home pregnancy test) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (1st dose given on 28Apr2021 (more than 36 days ago)) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006LUA) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Jun-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (1st dose given on 28Apr2021 (more than 36 days ago)). On an unknown date, the patient experienced EXPOSURE DURING PREGNANCY (she found out that she was pregnant through a home pregnancy test). At the time of the report, EXPOSURE DURING PREGNANCY (she found out that she was pregnant through a home pregnancy test) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (1st dose given on 28Apr2021 (more than 36 days ago)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Information has been received from a registered nurse concerning a 14 year old patient of unknown gender. The patient's concurrent conditions, medical history and concomitant therapy were not reported. On 19-FEB-2016, the patient was vaccinated with the third dose of an improperly stored GARDASIL 9 (dose and route of administration were not reported, lot # L048237 and expiration date 08-MAY-2017) (temperature: -10 degree Centigrade, time frame: over a two day period with a cumulative of 12 hours (2 cycles)). No adverse effect was reported. This is one of several reports received from the same reporter. Additional information has been requested.
30 hrs after immuniz dev fever, then febrile seizure 9 days after immz dev. urticarial rash.
Pregnant; This spontaneous pregnancy case was reported by a consumer and describes the occurrence of PREGNANCY (Pregnant) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On an unknown date, the patient experienced PREGNANCY (Pregnant). At the time of the report, PREGNANCY (Pregnant) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication details was reported. No treatment medication details was reported.; Sender's Comments: This is a case of product exposure during pregnancy with no associated AEs for this female. Patient will continue to be contacted for further monitoring of AEs during the pregnancy.
This spontaneous report as received from a nurse refers to roughly 20 unspecified patients of unknown age. On an unknown date, roughly 20 unspecified patients were vaccinated with (Oka/Merck) VARIVAX (injection, strength, dose, frequency, route of administration and indication were not provided) that reached 18.5 for 10 hours and 44 minutes. This range was outside of storage conditions in product insert; however, the reporter stated that their in house stability data could suppose those conditions mentioned above that the (Oka/Merck) VARIVAX was exposed to. No concomitant medication was reported. No adverse effects reported. No product quality complaint (PQC) was reported. The outcome of events was unknown. No further adverse information was available.   Follow up information (after previous telephone attempt to obtain follow-up information which has been unsuccessful) has been received from nurse concerning (Oka/Merck) VARIVAX temperature excursion and one patient (patient ID#120680) of unspecified age and gender who was vaccinated with (Oka/Merck) VARIVAX (injection, strength, dose, frequency, route of administration and indication were not provided) (lot # J012817, exp date: 10-OCT-2015) that reached 18.5 F for 10 hours and 44 minutes. This is one of several reports received from the same source. Additional information has been requested.
fainting spell; almost passed out; dizzy spells; weak; This is a spontaneous report from a contactable consumer (patient herself). A 22-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot: EL3246), via an unspecified route of administration on 07Jan2021 in right upper arm shoulder area at single dose for prevent covid. Medical history included ongoing acne. Concomitant medication included doxycycline from 2020 (taking it 6 months ago) and ongoing for acne. Patient stated that she got the Covid vaccine yesterday 07Jan2021 and almost passed out in her kitchen after a couple hours. Patient stated got in shower had dizzy spells and was weak 07Jan2021, she felt better now. Patient stated that she was a small girl of 105 pounds and the dose could have made her sick. She wanted to make sure she did not need to go and be seen. Patent had another spell in shower this morning and stated that the fainting spell and feeling weak started at 9:00 yesterday evening on 07Jan2021. Outcome of dizzy spells was recovering, and outcome of other events were unknown.
Child complained on 8/13/16 that his arm (L) arm where Tdap was given was sore and burned a little. Mom put ice packs and gave client MOTRIN. States when woke up 8/1416 about 7:00 am child (R) arm was red, swollen, hot, and harden feeling down to elbow. Went to ER and was diagnosed with cellulitis and given Cefadroxil 250 mg and Q 12 hrs for 10 days. Mom continues to use ice packs and MOTRIN along with antibiotic. Swelling has gone down to just at the site where vaccine was given. Mom states child is doing much better.
Felt a little off, took watch ECG and it kept giving Inconclusive. Did ECG on a 2 lead devise and it kept giving Irregular Heart Rate. In a nut shell, looks like I'm having PVC's non stop after this booster shot. HRV was wacky. Shot up to the 300s when it's normally in the 50s. Going on day 12 after the booster shot. Beside the normal temperature and feeling tired the day after, I didn't notice anything off until a few days after the shot. I finally have all normal ECGs today, but my HRV is still wacky.
Information has been received from a registered nurse concerning a 24 year old male who was vaccinated with a first and second dose of MMR II in "1980's" and in 1994. In approximately April 2006, the patient was found to have no antibodies to mumps. It was noted that he was revaccinated on 18-APR-2006. Unspecified medical attention was sought. There was no product quality complaint involved. Additional information has been requested.
Seconds after the injection I had severe dizziness and was sore on the vaccine sight.  Within 12 hrs of that I experienced stomach flu-like symptoms, next it was body aches and difficulties breathing. My chest began hurting by my heart. My symptoms worsened by the hour
Pt recve 2 doses of Recomb w/no rxn; On 1FEB91 recvd 3rd dose & devel urticaria on arms, nausea, arthralgia & myalgia; tx DPH & later recovered;
Initial literature report received on 20 Dec 2010: This report consisted of cases retrieved from the Vaccine Injury Compensation Program database. A query of the database was conducted to identify potentially relevant cases based on a claimed injury of shoulder pain, arm pain, shoulder dysfunction, frozen shoulder, adhesive capsulitis, or shoulder bursitis. Brachial neuritis was also included since this injury was frequently claimed when the arm was involved regardless of the actual diagnosis. Case histories of all submitted medical records were reviewed in details to verify vaccination date, symptom onset and clinical course. This patient with no history of shoulder dysfunction, was vaccinated with influenza vaccine (manufacturer unknown, batch number: unknown) on unknown date. It was reported that the vaccine administration led to shoulder injury with significant shoulder pain and dysfunction. The symptoms lasted for more than six months. The outcome was not reported. The authors commented that they believe that this type of phenomenon is not due to a specific vaccine but results from injection of a vaccine antigen to which a person has previously been sensitized as a result of previous naturally occurring infection or past vaccination. This concept is consistent with the vaccines which were given in this case series, namely influenza and tetanus vaccines which are given repeatedly over time. This clinical case series provides additional evidence supporting the report that vaccine administration in the upper third of the deltoid area can have long-lasting consequences unrelated to the specific vaccine administered.
This spontaneous report was received from a medical assistant concerning an unspecified number of patients (demographics unknown). On unspecified dates since 29-JUN-2015, the patients were vaccinated with doses of improperly stored GARDASIL (dose, route and lot# not provided). No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.
Painful and heated swelling of upper arm. Motion was extremely difficult. Warranted an ER visit.
Migrane, Chills, Fever, Back aches, Foot pain . I couldn't lift my arm at the injection site. Vomiting, eyes hurt
Pfizer 4/5/21, 4/26/21, 12/3/21. Positive on 2/10/23
Patient received vaccine and within 10-15 minutes started complaining that his right arm was itching. His arm was red above and below the bandaid so I had him wait awhile longer to make sure it was not the Band-Aid causing a skin reaction. After giving another patient his shot I came back to the patient and his arm was more red above and below the Band-Aid than it had been before. I instructed the nurse to give him 25mg of Benadryl at that time. After stating he was not having any scratchy throat, or shortness of breath, he was allowed to go to group. I checked on him again in an hour, right before I left facility and at that time the redness looked more like hives but still just around the injection site and no other symptoms reported. I informed the nurse to give 25 mg every 4 hours for the next 24 hours and I would call and check on him later that day and again in the morning. Any signs of airway compromise he will need to see his dr. Nurse understood orders given. I called facility back at 3 pm and he had received his next dose of Benadryl and when he did his arm was not near as red and the hives were starting to go away. I called the next day and the nurse had seen him at lunch and he did not have any hives at all, no redness, itching subsided, and no other complaints.
Swollen Lymph Nodes Left Underarm.... Vaccine on the Feb 2, 2021 and Annual Mammogram on Feb 6, 2021, Returned for Sonogram on Feb 9, 2021. Scheduled for second Sonogram May 10, 2021 as follow up.